Stay updated on Safety of hESC-RPE in Stargardt's Clinical Trial
Sign up to get notified when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.

Latest updates to the Safety of hESC-RPE in Stargardt's Clinical Trial page
- Check4 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No other substantive changes to core content, pricing, stock, or time-related information were detected.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to retinal disorders, specifically Stargardt disease and congenital diseases. Notably, previous mentions of age-related macular degeneration and specific location details have been removed.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Safety of hESC-RPE in Stargardt's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of hESC-RPE in Stargardt's Clinical Trial page.